论文部分内容阅读
加拿大卫生部(Health Canada)批准UCB公司的Cimzia(TM)(certolizumab pegol)用于治疗中度至重度类风湿性关节炎成人患者。Cimzia(TM)是一种与poly(ethylene glycol)共价结合的抗TNF药物。此项批准基于一项包括4个中心的、安慰剂对照的、III期综合性临床试验的数据。该试验包括?
Health Canada approved UCB’s Cimzia (certolizumab pegol) for the treatment of adults with moderate to severe rheumatoid arthritis. Cimzia (TM) is an anti-TNF drug that is covalently attached to poly (ethylene glycol). The approval is based on data from a four-center, placebo-controlled, phase III comprehensive clinical trial. This test includes?